Product
NS-065/NCNP-01
1 clinical trial
1 indication
Indication
Duchenne muscular dystrophyClinical trial
A Phase II, Open-Label, Extension Study to Assess the Safety and Efficacy of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD)Status: Completed, Estimated PCD: 2021-10-20